{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T17:23:44Z","timestamp":1764350624565,"version":"3.46.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.humpath.2025.105969","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:02:19Z","timestamp":1761930139000},"page":"105969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Myoepithelial and epithelial-myoepithelial clinically advanced and metastatic carcinomas of salivary gland: A comparative comprehensive genomic profiling study"],"prefix":"10.1016","volume":"166","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1719-7164","authenticated-orcid":false,"given":"C\u00e9line S.C.","family":"Hardy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin M.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Pavlick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard S.P.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey S.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Zaccarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2025.105969_bib1","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41467-017-01178-z","article-title":"Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions","volume":"8","author":"Dalin","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2025.105969_bib2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1177\/0194599815594788","article-title":"Epithelial-myoepithelial carcinoma of the salivary glands: an analysis of 246 cases","volume":"153","author":"V\u00e1zquez","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.humpath.2025.105969_bib3","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1177\/0194599816637605","article-title":"Prognostic factors in myoepithelial carcinoma of the major salivary glands","volume":"154","author":"Xiao","year":"2016","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.humpath.2025.105969_bib4","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s12094-015-1329-4","article-title":"Salivary gland myoepithelial carcinoma","volume":"17","author":"Vilar-Gonz\u00e1lez","year":"2015","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.humpath.2025.105969_bib5","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/PAS.0000000000001258","article-title":"Diagnostic significance of HRAS mutations in epithelial-myoepithelial carcinomas exhibiting a broad histopathologic spectrum","volume":"43","author":"Urano","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105969_bib6","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/PAS.0000000000001673","article-title":"The diagnostic utility of RAS Q61R mutation-specific immunohistochemistry in epithelial-myoepithelial carcinoma","volume":"45","author":"Nakaguro","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105969_bib7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.21873\/cdp.10233","article-title":"Mutational signatures in salivary gland carcinomas","volume":"3","author":"Chrysovergis","year":"2023","journal-title":"Cancer Diagn Progn"},{"key":"10.1016\/j.humpath.2025.105969_bib8","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nbt.2696","article-title":"Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing","volume":"31","author":"Frampton","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.humpath.2025.105969_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med"},{"key":"10.1016\/j.humpath.2025.105969_bib10","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jmoldx.2019.06.011","article-title":"A novel next-generation sequencing approach to detecting microsatellite instability and pan-tumor characterization of 1000 microsatellite instability-high cases in 67,000 patient samples","volume":"21","author":"Trabucco","year":"2019","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.humpath.2025.105969_bib11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ccell.2020.04.012","article-title":"Comprehensive analysis of genetic ancestry and its molecular correlates in cancer","volume":"37","author":"Carrot-Zhang","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humpath.2025.105969_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105492","article-title":"Combined inhibition of MTAP and MAT2a mimics synthetic lethality in tumor models via PRMT5 inhibition","volume":"300","author":"Bedard","year":"2024","journal-title":"J Biol Chem"},{"year":"2021","series-title":"An open label, phase 1, treatment study to evaluate the safety, pharmacokinetics and pharmacodynamics of IDE397 (MAT2A inhibitor) in adult participants with advanced solid tumors","key":"10.1016\/j.humpath.2025.105969_bib13"},{"key":"10.1016\/j.humpath.2025.105969_bib14","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa1813904","article-title":"Alpelisib for PIK3CA-Mutated, hormone receptor-positive advanced breast cancer","volume":"380","author":"Andr\u00e9","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2025.105969_bib15","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa2214131","article-title":"Capivasertib in hormone receptor-positive advanced breast cancer","volume":"388","author":"Turner","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2025.105969_bib16","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1177\/014556131709600319","article-title":"The rising incidence of major salivary gland cancer in the United States","volume":"96","author":"Del Signore","year":"2017","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.humpath.2025.105969_bib17","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/00000478-200006000-00001","article-title":"Myoepithelial carcinoma of the salivary glands: a clinicopathologic study of 25 patients","volume":"24","author":"Savera","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105969_bib18","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/jclinpath-2018-205216","article-title":"p16","volume":"71","author":"Serra","year":"2018","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2025.105969_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12885-024-13421-0","article-title":"Potentially actionable molecular alterations in particular related to poor oncologic outcomes in salivary gland carcinomas","volume":"25","author":"Pikul","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.humpath.2025.105969_bib20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/1066896917709350","article-title":"Salivary gland secretory carcinoma with high-grade transformation, CDKN2A\/B loss, distant metastasis, and lack of sustained response to crizotinib","volume":"25","author":"Cipriani","year":"2017","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105969_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/PAP.0000000000000291","article-title":"Molecular pathology of salivary gland neoplasms: diagnostic, prognostic, and predictive perspective","volume":"28","author":"Toper","year":"2021","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.humpath.2025.105969_bib22","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.42970","article-title":"Actionable structural variant detection via RNA-NGS and DNA-NGS in patients with advanced non-small cell lung cancer","volume":"7","author":"Owen","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.humpath.2025.105969_bib23","doi-asserted-by":"crossref","first-page":"18224","DOI":"10.18632\/oncotarget.4015","article-title":"Targeted next generation sequencing of parotid gland cancer uncovers genetic heterogeneity","volume":"6","author":"Gr\u00fcnewald","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2025.105969_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s12105-024-01698-3","article-title":"Pitfalls in diagnosis of myoepithelial carcinoma of salivary glands: a study of 3 cases with cytologic-histologic correlation and molecular analysis","volume":"18","author":"Agarwal","year":"2024","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.humpath.2025.105969_bib25","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s12105-021-01346-0","article-title":"Myoepithelial carcinoma Ex-Pleomorphic adenoma: a rare pathology misdiagnosed as pleomorphic adenoma; with a novel TERT promoter mutation and high PD-L1 expression","volume":"16","author":"Cormier","year":"2022","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.humpath.2025.105969_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12040873","article-title":"Prognostic impact of PD-L1 expression in malignant salivary gland tumors as assessed by established scoring criteria: Tumor proportion score (TPS), combined positivity score (CPS), and immune cell (IC) infiltrate","volume":"12","author":"Witte","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2025.105969_bib27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2025.105969_bib28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.path.2020.10.002","article-title":"Epithelial-myoepithelial carcinoma","volume":"14","author":"Nakaguro","year":"2021","journal-title":"Surg Pathol Clin"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725002564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725002564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T17:18:05Z","timestamp":1764350285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817725002564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":28,"alternative-id":["S0046817725002564"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105969","relation":{},"ISSN":["0046-8177"],"issn-type":[{"type":"print","value":"0046-8177"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myoepithelial and epithelial-myoepithelial clinically advanced and metastatic carcinomas of salivary gland: A comparative comprehensive genomic profiling study","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105969","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105969"}}